Overview
- 5 public-safe observations are available for this inspection.
- 5 structured CFR citations are represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
19 Jan 2011
21 CFR 820.30(g)
Design validation- Lack of or inadequate procedures
Cited by Jeffrey R Wooley
19 Jan 2011
21 CFR 820.50
Purchasing controls, Lack of or inadequate procedures
Cited by Jeffrey R Wooley
19 Jan 2011
21 CFR 820.90(a)
Nonconforming product, Lack of or inadequate procedures
Cited by Jeffrey R Wooley
Inspected site
GMGalt Medical CorporationGarland, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 803.50(a)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.30(g) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.50 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.75(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.90(a) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 5 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere